<DOC>
	<DOCNO>NCT01609959</DOCNO>
	<brief_summary>The purpose study compare blood pressure lower effect azilsartan valsartan Japanese patient hypertension already take normal-dose angiotensin II receptor blocker .</brief_summary>
	<brief_title>New Angiotensin II Receptor Blocker Azilsartan Study Stronger Blood Pressure Lowering</brief_title>
	<detailed_description>Hypertension play major role development cardiovascular disease . Several guideline require strict control blood pressure prevent cardiovascular event ; however , control often poor . A new angiotensin II receptor blocker ( ARB ) , azilsartan , first drug superior ARBs blood pressure lower phase III clinical trial Japan . We try evaluate effect azilsartan blood pressure lower Japanese patient hypertension already take normal-dose ARBs , compare valsartan .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Angiotensin II</mesh_term>
	<mesh_term>Angiotensinogen</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<criteria>Hypertensive patient treat normaldose angiotensin II receptor blocker ( ARBs ) Japan Normaldose ARBs Japan define follow : losartan potassium 50 mg , candesartan cilexetil 8 mg , valsartan 80 mg , telmisartan 40 mg , olmesartan medoxomil 20 mg , irbesartan 100mg per day . Hypersensitivity azilsartan valsartan Pregnant female History azilsartan use within 3 month</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Angiotensin II Receptor Blocker</keyword>
	<keyword>Azilsartan</keyword>
	<keyword>Valsartan</keyword>
</DOC>